Here’s some high hopes for a coronavirus breakthrough this Memorial Weekend.
A team of Canadian scientists, researchers from the University of Lethbridge, said a study that at least 13 cannabis plants were high in CBD that appeared to affect the ACE2 pathways that the virus uses to access the body.
Researcher Olga Kovalchuk, told CTV News,
“We were totally stunned at first, and then we were really happy.”
The results, in the online journal Preprints, indicate that hemp extracts high in CBD may help block proteins that provide a “gateway” for COVID-19 to enter host cells.
Kovalchuk’s husband, Igor, told the Calgary Herald.
“Our work could have a huge influence — there aren’t many drugs that have the potential of reducing infection by 70 to 80 percent.”
Olga said that just a handful of more than 800 varieties of sativa seemed to help. All were high in anti-inflammatory CBD — but low in THC, the part that produces the cannabis high.
“The key thing is not that any cannabis you would pick up at the store will do the trick.”
While our most effective extracts require further large-scale validation, our study is crucial for the future analysis of the effects of medical cannabis on COVID-19.”
The study, which has yet to be peer-reviewed, was carried out in partnership with Pathway Rx, a cannabis therapy research company, and Swysh Inc., a cannabinoid-based research company.
“Given the current dire and rapidly evolving epidemiological situation, every possible therapeutic opportunity and avenue must be considered.”
(Photos, Wikipedia, Wikimedia Commons; via NY Post)